ID   WAe009-A-1F
AC   CVCL_D6SA
SY   TSC2-/- H9; ANZHe010-A-1F
DR   BioSamples; SAMEA114469194
DR   hPSCreg; WAe009-A-1F
RX   PubMed=38574666;
CC   From: Anzhen Hospital, Capital Medical University; Beijing; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; 12363; TSC2.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
RX   PubMed=38574666; DOI=10.1016/j.scr.2024.103399;
RA   Zhang S.-Y., Fan J.-Q., Sun H.-R., Hao X.-Y., He Y.-H.;
RT   "Generation of a TSC2 knockout embryonic stem cell line by CRISPR/Cas9
RT   editing.";
RL   Stem Cell Res. 77:103399-103399(2024).
//